Midfacial Tumor
Conditions
Interventions
Experimental Group:The core technologies of this experiment were used to repair the defects in the middle area of the surface, including the evaluation and design of digital virtual technology before
Control Group:Covered with conventional skins or covered with open space or pseudo-compounds.
Sponsors
Beijing Tongren Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with malignant tumors in the middle of the face diagnosed by pathology [staging refer to AJCC-TNM staging the eighth edition], and there may be defects left after surgery, undergo phase I surgical repair; 2. Age 18-80 years old; 3. Initial treatment of patients (primary, no history of surgery, radiotherapy and chemotherapy); 4. KPS score of 80 points or above; 5. The patient has no contraindications to surgery or other factors of the test; 6. Patients voluntarily join the group, sign informed consent, and have good compliance.
Exclusion criteria
Exclusion criteria: 1. Patients with distant metastases; 2. Those who have central nervous system disorders or lose self-awareness due to mental illness; 3. Major organ dysfunction (including heart, lungs, liver, kidneys, etc.); 4. Those who have other malignant tumors within two years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| University of Washinqton head and neck Quatity-of-life, UW-QOL; | — |
Secondary
| Measure | Time frame |
|---|---|
| Eye function;Middle ear function;Nasal function;Oral function;Oral health assessment;Pronunciation function assessment;Assessment of swallowing function;Total quality of life assessment;Imaging assessment; | — |
Countries
China
Contacts
Public ContactZhong Qi
Beijing Tongren Hospital Affiliated to Capital Medical University
Outcome results
None listed